Search Results - "Marskaya, N. A."

Acute cerebrovascular accidents in patients with new coronavirus infection COVID-19 by Shamalov, N. A., Klimov, L. V., Soldatov, M. A., Kiseleva, T. V., Shamalova, V. N., Marskaya, N. A., Lyang, O. V.

“…The incidence of neurological complications in COVID-19 can reach 8–10% of all cases of new coronavirus infection; acute cerebrovascular accidents (ACA)…”
Get full text

Intravenous thrombolytic therapy of ischemic stroke with the drug Revelisa in real clinical practice: results of the IVT-AIS-R study by Soldatov, M A, Klimov, L V, Tolmachev, A P, Kiseleva, T V, Androfagina, O V, Beketova, E M, Belkina, S N, Borisov, D N, Karpov, D Yu, Krasyuk, M S, Kucheryavaya, M V, Minina, Yu D, Novikov, D G, Rogozhnikova, N V, Tabakman, S V, Teliatnik, Yu A, Tretyakov, K V, Fadeeva, A S, Khan, D S, Chirkov, A N, Marskaya, N A, Shamalov, N A

“…Evaluation of the safety and effectiveness of thrombolytic therapy (TLT) with the drug Revelisa (alteplase) in patients with ischemic stroke (AI) in real…”
Get more information

Intravenous thrombolytic therapy with Revelisa of ischemic stroke in real-world clinical practice: interim results of an open-label, prospective, multicenter, non-interventional study IVT-AIS-R by Soldatov, M A, Marskaya, N A, Barsegova, K A, Androfagina, O V, Borisov, D N, Karpov, D Yu, Kishinevsky, M V, Kucheryavaya, M V, Tabakman, S V, Telyatnik, Yu A, Fadeeva, A S, Khan, D S, Chirkov, A N, Shamalov, N A

“…To assess the safety and efficacy of Revelisa in patients with ischemic stroke in real-world clinical practice. The interim analysis of an open-label,…”
Get more information